CRISPR-Cas9 System: A Prospective Pathway toward Combatting Antibiotic Resistance
Antibiotics · 19.06.2023 · 12 (6) · 1075
DOI: 10.3390/antibiotics12061075 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antibiotics, online erschienen am 19.06.2023. Verfasst von Muhammad Uzair Javed und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Quaid-i-Azam University, Islamabad 45320, Pakistan. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Antibiotic resistance is rising to dangerously high levels throughout the world. To cope with this problem, scientists are working on CRISPR-based research so that antibiotic-resistant bacteria can be killed and attacked almost as quickly as antibiotic-sensitive bacteria. Nuclease activity is found in Cas9, which can be programmed with a specific target sequence. This mechanism will only attack pathogens in the microbiota while preserving commensal bacteria. This article portrays the delivery methods used in the CRISPR-Cas system, which are both viral and non-viral, along with its implications and challenges, such as microbial dysbiosis, off-target effects, and failure to counteract intracellular infections. CRISPR-based systems have a lot of applications, such as correcting mutations, developing diagnostics for infectious diseases, improving crops productions, improving breeding techniques, etc. In the future, CRISPR-based systems will revolutionize the world by curing diseases, improving agriculture, and repairing genetic disorders. Though all the drawbacks of the technology, CRISPR carries great potential; thus, the modification and consideration of some aspects could result in a mind-blowing technique to attain all the applications listed and present a game-changing potential.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biotechnology, Quaid-i-Azam University, Islamabad 45320, Pakistan.
- Institute of Industrial Biotechnology, Government College University, Lahore 54000, Pakistan.
- Department of Animal Production and Veterinary Public Health, Faculty of Veterinary Medicine, University of Life Sciences "King Mihai I" from Timişoara, 300645 Timișoara, Romania.
ORCID-Profile: Kalman Imre
Zitieren
APA
Javed, M. U., Hayat, M. T., Mukhtar, H., & Imre, K. (2023). CRISPR-Cas9 System: A Prospective Pathway toward Combatting Antibiotic Resistance. Antibiotics, 12(6), 1075. https://doi.org/10.3390/antibiotics12061075
Vancouver
Javed MU, Hayat MT, Mukhtar H, Imre K. CRISPR-Cas9 System: A Prospective Pathway toward Combatting Antibiotic Resistance. Antibiotics. 2023;12(6):1075. doi:10.3390/antibiotics12061075
BibTeX
@article{Javed2023,
author = {Javed, Muhammad Uzair and Hayat, Muhammad Tahir and Mukhtar, Hamid and Imre, Kalman},
title = {CRISPR-Cas9 System: A Prospective Pathway toward Combatting Antibiotic Resistance},
journal = {Antibiotics},
year = {2023},
volume = {12},
number = {6},
pages = {1075},
doi = {10.3390/antibiotics12061075}
}
EUVIMED